[ Price : $8.95]
Advocacy group Public Citizen files a petition urging FDA to ban prescription drug direct-to-consumer advertising.[ Price : $8.95]
FDA accepts for review Revolution Medicines' NDA for daraxonrasib, an investigational oral RAS-targeted therapy for patients with ...[ Price : $8.95]
Attorney Megan Robertsons analysis of 2026 FDA Warning Letters shows that CDER has been the most active Center, going after telehe...[ Price : $8.95]
FDA releases the form FDA-483 issued following a 2026 inspection at the CSL Behring biological drug manufacturing facility in Marb...[ Price : $8.95]
Two Sheppard attorneys say an FDA proposal to require complete safety and risk information within the content of direct-to-consume...[ Price : $8.95]
Attorney Jake Leys says MDUFA 6 reauthorization has moved from negotiations into writing the commitment letter that spells out all...[ Price : $8.95]
FDA approves GSK's Jideytro (zidesamtinib) for certain adults with locally advanced or metastatic ROS1-positive non-small cell lun...[ Price : $8.95]
FDA investigators cite contract research organization Cliantha Research over data integrity, documentation and clinical research d...